Emerging emerging markets for Chinese medicine import and export | new trend of internationalization of traditional Chinese medicine

Pharmaceutical Network November 24, 2017 three quarters of China's import and export of traditional Chinese medicine 3.71 billion US dollars, an increase of 7.40%, of which 2.6 billion US dollars exports, down 0.27% year-on-year; imports of 1.116 billion US dollars, up 30.81% .

In the first three quarters of 2017, the export of Chinese Herbal Medicine Pieces was quite eye-catching, with an increase of 49.68% over the same period of the previous year, but the increase in export value was not significant. Export performance has been very good. The exports in the first three quarters decreased slightly year-on-year, Big.

In the first three quarters of 2017, Chinese medicines were exported to 118 countries and regions, of which the Asian region is both a traditional market and a major market for traditional Chinese medicine exports, and exports of Chinese medicines to Asian countries and regions amounted to US $ 1.5 billion in the first three quarters of 2017, A slight decrease of 0.06% from the same period of previous year, accounting for 57.73% of the total, mainly to the United States, Japan, Hong Kong, China, ASEAN and South Korea.

United States: In the past, Japan was the largest market for Chinese herbal medicine exports. The United States has been only the second or third largest market for Chinese herbal medicine exports and maintained a relatively high growth in the past two years. However, in the first three quarters of 2017, the U.S. market China's exports to the United States in the first quarter of 2017 amounted to 425 million US dollars, accounting for 16.36% of China's exports of Chinese medicine, of which raw materials of Chinese herbal medicines and health products exports to the United States the same period last year Larger increase.

Japan: China's exports to the Japanese market in the first three quarters increased by 36.40% year-on-year with an export volume of 370 million U.S. dollars, up slightly by 3.35% year-on-year. China's exports to Japan are mainly extracts and Chinese herbal medicines, Export of extracts in terms of both the quantity and the amount of exports have a year-on-year growth.

Hong Kong, China: Hong Kong continues to be the third largest market for mainland Chinese medicine exports. Its exports in the first three quarters were 340 million U.S. dollars, down by 15.30% on a year-on-year basis. The role of Hong Kong as a transit point for export trade is still on the decline.

Korea: In the first three quarters of 2017, China's export of traditional Chinese medicine to South Korea was 150 million U.S. dollars, down 13.47% from the same period of last year, accounting for 5.85% of China's total exports of Chinese medicine. China's exports to South Korea are mainly extracts and Chinese herbal medicines. In the first three quarters, Exports of Korean herbs and Pieces were 73,394,500 US dollars, a year-on-year decrease of 20.63%.

Europe: China exported 444 million U.S. dollars of Chinese traditional medicine to Europe in the first three months of 2017, down slightly by 1.66% year-on-year and accounting for 17.10% of China's total exports of Chinese medicine. China's exports to Europe are mainly extracts, accounting for 71.99% of China's exports of Chinese medicine %. China's exports of Chinese medicines in several major markets in Europe were Germany, Spain and France.

Since 2011, the United States has replaced Japan as China's largest extract market, the United States extract is mainly used for the production of dietary supplements and food additives, the demand for raw materials has been relatively strong.Extracts of Japan's exports to Japan in addition to ordinary extracts of exports , Mainly for the Japanese Kampo raw materials, while China's exports of Korean extract is mainly used for its health products and cosmetic raw material.

The main medicines exported to Hong Kong from the Mainland are wolfberry and ginseng, but it is noteworthy that Hong Kong has also been the major export market of Cordyceps in the Mainland. As the price continues to rise, the volume of exports of Cordyceps sinensis has been declining. The price of Cordyceps sinensis in 2012 For some time there was a sign of rising weakness. The export price of Cordyceps sinensis reached 29348.34 USD / kg in 2013, up 16.07% over the same period of last year while the export volume contracted to 305kg, down 57.70%. The efficacy of Cordyceps sinensis has been recognized by overseas Chinese and the demand is still The export volume of Cordyceps sinensis to Hong Kong has risen slightly in 2015, and the export price has been relatively stable. In the first three quarters of this year, the mainland exported 469 kilograms of Cordyceps sinensis to Hong Kong with an export price of 22,506.55 U.S. dollars / kg, an increase of 18.56% over the same period of last year.

To some extent, the export situation of proprietary Chinese medicines can be regarded as the benchmark for the internationalization of traditional Chinese medicine, but proprietary Chinese medicines are still mainly consumed by the Chinese community abroad with limited increase in market capacity.

The EU is the largest plant medicine market in the world and one of the major target markets for export of proprietary Chinese medicines in recent years. medicine Hot topics in the industry have also become traditional Chinese medicine drug As a result, the export of proprietary Chinese medicines to the EU has shown a downward trend since the closure of the EU Directive 2004/24 / EC on April 30, 2011. However, in the first three quarters of 2017 , China's export value of proprietary Chinese medicines to the former 15 EU countries was US $ 5,005,300, an increase of 8.73% over the same period of last year, while that of the 12 countries with the eastward expansion of the EU was 2,356,900 US dollars, an increase of 3.59% over the same period of last year.

My country Health products Export has always been based on raw materials, the lack of high value-added health care products.The United States and Japan have been the main market for China's health products exports, of which fish oil products account for more than 55% of our exports to the United States health care products.Our country's health care in Japan The main export products are royal jelly products, exports account for about 90% of China's health products exports to Japan in recent years, royal jelly international standard-setting work made a breakthrough, our royal jelly in industrial development, quality supervision, scientific research and so on Huge changes, especially the dominance of international prices, have intensified.

In the first three quarters of 2017, the import volume of China's bird's nest was 48,341 kg, an increase of 84.89% over the same period of last year with an import price of 1,683.43 US dollars / kg, up 12.88% over the same period of last year, mainly due to the high consumption of domestic bird's nest products. One of the big data released by Ali, "2017 China New Year big data report," bird nest in the hot potatoes ranked fifth.

In the first three quarters of 2017, the import of antler in our country was 485,861 kg, an increase of 22.88% over the same period of last year. The import price was 58.63 USD / kg, up by 221.30% over the same period of last year. Imported 98.30% of our country's antler was from New Zealand.

In the first three quarters of 2017, China's ginseng exports were 1,177,909 kg, down 18.36% over the same period of last year, and the export price was 50.04 U.S.dollars / kg, down 31.87% from the same period of last year. The decline of China's ginseng exports was mainly due to weaker demand in Japan and Europe.

In the first three quarters of 2017, there were 3,415 Chinese-exporting enterprises, and private-owned enterprises were the major force in promoting the export of Chinese medicine. The number of exporters was 2,844 and the export value was 1.672 billion U.S. dollars, down 3.38% year-on-year, accounting for 64.49% of the total. The number of exporters of capital-owned enterprises was 331, with an export volume of 620 million U.S. dollars, an increase of 3.84% over the same period of last year, accounting for 23.92% of the total. The number of exporters from state-owned enterprises was 234, with an export volume of 300 million U.S. dollars, up 10.67% Enterprises accounted for 11.52% of the total amount of exports, state-owned enterprises increased their exports year on year relatively large.

In the first three quarters of 2017, there were 1425 Chinese-funded import enterprises, 889 importers of private enterprises and an import volume of 637 million U.S. dollars, up 53.08% over the same period of the previous year, accounting for 57.07% of the total; the number of foreign-funded enterprises imported was 443, The import volume was 368 million U.S. dollars, up by 13.80% over the same period of the previous year, with the amount of imports accounting for 33.00%. The number of state-owned enterprises imported was 92, with the import amount of 110 million U.S. dollars, down slightly by 3.09% over the same period of last year, while that of state-owned enterprises accounted for 9.86% .